New Trends in Cancer for the 21st Century: Proceedings of the International Symposium on Cancer: New Trends in Cancer for the 21st Century, held November 10–13, 2002, in Valencia, Spain: Advances in Experimental Medicine and Biology, cartea 532
Editat de Antonio Llombart-Bosch, Vicente Felipoen Limba Engleză Paperback – 12 oct 2012
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 373.47 lei 6-8 săpt. | |
Springer Us – 12 oct 2012 | 373.47 lei 6-8 săpt. | |
Hardback (1) | 585.22 lei 6-8 săpt. | |
Springer Verlag – 30 iul 2003 | 585.22 lei 6-8 săpt. |
Din seria Advances in Experimental Medicine and Biology
- 9% Preț: 719.56 lei
- 5% Preț: 717.00 lei
- 5% Preț: 717.00 lei
- 15% Preț: 640.24 lei
- 5% Preț: 715.71 lei
- 5% Preț: 716.28 lei
- 20% Preț: 691.93 lei
- 5% Preț: 1031.00 lei
- 5% Preț: 820.42 lei
- 5% Preț: 716.28 lei
- 15% Preț: 641.38 lei
- 5% Preț: 717.20 lei
- 5% Preț: 715.35 lei
- 5% Preț: 1113.83 lei
- 20% Preț: 1161.71 lei
- 5% Preț: 1170.51 lei
- 18% Preț: 1119.87 lei
- 5% Preț: 1288.48 lei
- 5% Preț: 1164.67 lei
- 5% Preț: 1101.73 lei
- 18% Preț: 1123.67 lei
- 5% Preț: 1435.64 lei
- 20% Preț: 1044.10 lei
- 18% Preț: 946.39 lei
- 5% Preț: 292.57 lei
- 18% Preț: 957.62 lei
- 18% Preț: 1235.76 lei
- 5% Preț: 1231.55 lei
- 5% Preț: 1292.30 lei
- 5% Preț: 1102.10 lei
- 18% Preț: 1132.81 lei
- 5% Preț: 1165.19 lei
- 5% Preț: 1418.48 lei
- 5% Preț: 1305.63 lei
- 18% Preț: 1417.72 lei
- 18% Preț: 1412.99 lei
- 24% Preț: 806.15 lei
- 18% Preț: 1243.29 lei
- 5% Preț: 1429.44 lei
- 5% Preț: 1618.70 lei
- 5% Preț: 1305.12 lei
- 18% Preț: 1124.92 lei
- 5% Preț: 1097.54 lei
- 15% Preț: 649.87 lei
- 5% Preț: 1097.54 lei
- 18% Preț: 945.79 lei
- 5% Preț: 1123.13 lei
- 20% Preț: 816.43 lei
Preț: 373.47 lei
Preț vechi: 393.13 lei
-5% Nou
Puncte Express: 560
Preț estimativ în valută:
71.47€ • 74.52$ • 59.40£
71.47€ • 74.52$ • 59.40£
Carte tipărită la comandă
Livrare economică 20 martie-03 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461349143
ISBN-10: 1461349141
Pagini: 308
Ilustrații: X, 293 p.
Dimensiuni: 178 x 254 x 16 mm
Greutate: 0.54 kg
Ediția:Softcover reprint of the original 1st ed. 2003
Editura: Springer Us
Colecția Springer
Seria Advances in Experimental Medicine and Biology
Locul publicării:New York, NY, United States
ISBN-10: 1461349141
Pagini: 308
Ilustrații: X, 293 p.
Dimensiuni: 178 x 254 x 16 mm
Greutate: 0.54 kg
Ediția:Softcover reprint of the original 1st ed. 2003
Editura: Springer Us
Colecția Springer
Seria Advances in Experimental Medicine and Biology
Locul publicării:New York, NY, United States
Public țintă
Professional/practitionerCuprins
Driving the Cell Cycle to Cancer.- Proliferation: The Cell Cycle.- Molecular Analysis of Gene Expression in Tumor Pathology.- Ewing Tumor Biology: Perspectives for Innovative Treatment Approaches.- Cancer Epigenetics: DNA Methylation and Chromatin Alterations in Human Cancer.- Molecular Analysis of Cancer Using DNA and Protein Microarrays.- Proteomic Approaches to the Diagnosis, Treatment, and Monitoring of Cancer.- Structural Basis of Tumoral Angiogenesis.- Matrix Metalloproteinases and Tumor Progression.- Angiogenesis Inhibitors and Their Therapeutic Potentials.- Mutated Tyrosine Kinases as Therapeutic Targets in Myeloid Leukemias.- Targeting PDGF Receptors in Cancer-Rationales and Proof of Concept Clinical Trials.- Immune-Promoted Tumor Cell Invasion and Metastasis. New considerations in cancer therapy.- Improvements of Survival in Nine Phase II Clinical Studies With Different Types of Cancer Upon Anti-Tumor Vaccination with an Autologous Tumor Cell Vaccine Modified by Virus Infection to Introduce Danger Signals.- Causation and Prevention of Solely Estrogen-Induced Oncogenesis: Similarities to Human Ductal Breast Cancer.- Cyclooxygenase-2 Inhibitors in Cancer Prevention and Treatment.- Exosomes for Immunotherapy of Cancer.- Breast Cancer Gene Expression Analysis ¡ª The Case for Dynamic Profiling..- Development of the Epidermal Growth Factor Receptor Inhibitor TARCEVATm (OSI-774).- Gefitinib (TRESSA, ZD 1839) for Non-Small Cell Lung Cancer (NSCLC): Recents Results and Further Strategies.- Mechanism of Action of Anti-HER2 Monoclonal Antibodies: Scientific Update on Trastuzumab and 2C4.- EORTC Research and Development: Achievements and Future Perspectives.- Contributors.